Unknown

Dataset Information

0

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.


ABSTRACT:

Objective

The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.

Methods

We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were referred to a tailored 8-week quitline intervention delivered by dedicated Quitline counsellors plus combination nicotine replacement therapy. The primary outcome was self-reported 6 months continuous abstinence from end of treatment (8 months from baseline). Secondary outcomes included additional smoking outcomes, mental health symptoms, substance use and quality of life. A within-trial economic evaluation was conducted.

Results

In total, 110 participants were recruited over 26 months and 91 had confirmed outcomes at 8 months post baseline. There was a difference in self-reported prolonged abstinence at 8-month follow-up between Quitlink (16%, n = 6) and control (2%, n = 1) conditions, which was not statistically significant (OR = 8.33 [0.52, 132.09] p = 0.131 available case). There was a significant difference in favour of the Quitlink condition on 7-day point prevalence at 2 months (OR = 8.06 [1.27, 51.00] p = 0.027 available case). Quitlink costs AU$9231 per additional quit achieved.

Conclusion

The Quitlink intervention did not result in significantly higher rates of prolonged abstinence at 8 months post baseline. However, engagement rates and satisfaction with the 'Quitlink' intervention were high. While underpowered, the Quitlink intervention shows promise. A powered trial to determine its effectiveness for improving long-term cessation is warranted.

SUBMITTER: Baker AL 

PROVIDER: S-EPMC10903138 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

'Quitlink': Outcomes of a randomised controlled trial of peer researcher facilitated referral to a tailored quitline tobacco treatment for people receiving mental health services.

Baker Amanda L AL   McCarter Kristen K   Turner Alyna A   Segan Catherine C   Castle David D   Brophy Lisa L   Borland Ron R   Kelly Peter J PJ   Bonevski Billie B   Baird Donita D   Filia Sacha S   Attia John J   Szwec Stuart S   Palazzi Kerrin K   White Sarah L SL   Williams Jill M JM   Wrobel Anna L AL   Ireland Andrew A   Saxby Karinna K   Ghijben Peter P   Petrie Dennis D   Sweeney Rohan R  

The Australian and New Zealand journal of psychiatry 20230623 3


<h4>Objective</h4>The aim of this study was to test the effectiveness of a tailored quitline tobacco treatment ('Quitlink') among people receiving support for mental health conditions.<h4>Methods</h4>We employed a prospective, cluster-randomised, open, blinded endpoint design to compare a control condition to our 'Quitlink' intervention. Both conditions received a brief intervention delivered by a peer researcher. Control participants received no further intervention. Quitlink participants were  ...[more]

Similar Datasets

| S-EPMC9199858 | biostudies-literature
| S-EPMC6434698 | biostudies-literature
| S-EPMC4747436 | biostudies-other
| S-EPMC5120741 | biostudies-literature
| S-EPMC10084529 | biostudies-literature
| S-EPMC4059482 | biostudies-literature
| S-EPMC7939019 | biostudies-literature
| S-EPMC4108050 | biostudies-literature
| S-EPMC4338305 | biostudies-literature
| S-EPMC4355239 | biostudies-literature